QMS Medical Allied Services Limited (NSE:QMSMEDI)
India · Delayed Price · Currency is INR 88.00
-4.00 (-4.35%)
Feb 19, 2026, 3:27 PM IST
NSE:QMSMEDI Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,730 | 1,560 | 1,221 | 1,040 | 1,463 | 1,220 |
Other Revenue | -0 | -0 | - | - | 0.01 | - |
| 1,730 | 1,560 | 1,221 | 1,040 | 1,463 | 1,220 | |
Revenue Growth (YoY) | 20.40% | 27.75% | 17.38% | -28.89% | 19.90% | 67.77% |
Cost of Revenue | 922.95 | 816 | 799.24 | 778.84 | 1,103 | 904.05 |
Gross Profit | 807.4 | 744.15 | 422.04 | 261.59 | 360.14 | 316.29 |
Selling, General & Admin | 150.94 | 127.56 | 67.88 | 55.18 | 46.66 | 28.31 |
Other Operating Expenses | 391.57 | 362.51 | 170.3 | 92.68 | 147.13 | 118.29 |
Operating Expenses | 584.32 | 528.32 | 272.58 | 158.59 | 205.41 | 153.95 |
Operating Income | 223.09 | 215.82 | 149.45 | 103 | 154.73 | 162.33 |
Interest Expense | -58.17 | -45.12 | -28.82 | -19.98 | -21.23 | -13.1 |
Interest & Investment Income | 13.86 | 13.86 | 4.56 | 6.23 | - | 0.03 |
Currency Exchange Gain (Loss) | 0.52 | 0.52 | -0.4 | 0.7 | 0.74 | -0.2 |
Other Non Operating Income (Expenses) | 3.44 | 1.38 | -2.43 | -2.9 | -3.19 | - |
EBT Excluding Unusual Items | 182.74 | 186.46 | 122.36 | 87.05 | 131.05 | 149.06 |
Gain (Loss) on Sale of Assets | 0.16 | 0.16 | - | - | 13.51 | - |
Pretax Income | 182.9 | 186.62 | 122.36 | 87.05 | 144.56 | 149.06 |
Income Tax Expense | 47.86 | 49.64 | 32.33 | 23.27 | 37.7 | 39.89 |
Earnings From Continuing Operations | 135.04 | 136.98 | 90.02 | 63.78 | 106.86 | 109.18 |
Minority Interest in Earnings | -17.16 | -16.06 | - | - | - | - |
Net Income | 117.88 | 120.92 | 90.02 | 63.78 | 106.86 | 109.18 |
Net Income to Common | 117.88 | 120.92 | 90.02 | 63.78 | 106.86 | 109.18 |
Net Income Growth | 14.56% | 34.32% | 41.14% | -40.31% | -2.12% | 71.83% |
Shares Outstanding (Basic) | 18 | 18 | 18 | 16 | 15 | 11 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 16 | 15 | 11 |
Shares Change (YoY) | 1.88% | - | 9.05% | 8.76% | 33.33% | - |
EPS (Basic) | 6.48 | 6.77 | 5.04 | 3.90 | 7.10 | 9.67 |
EPS (Diluted) | 6.48 | 6.77 | 5.04 | 3.90 | 7.10 | 9.67 |
EPS Growth | 12.45% | 34.33% | 29.34% | -45.12% | -26.59% | 71.83% |
Free Cash Flow | - | 166.82 | -11.94 | -288.46 | -38.05 | -57.95 |
Free Cash Flow Per Share | - | 9.35 | -0.67 | -17.62 | -2.53 | -5.13 |
Dividend Per Share | - | 0.500 | 0.500 | 0.500 | - | - |
Gross Margin | 46.66% | 47.70% | 34.56% | 25.14% | 24.61% | 25.92% |
Operating Margin | 12.89% | 13.83% | 12.24% | 9.90% | 10.57% | 13.30% |
Profit Margin | 6.81% | 7.75% | 7.37% | 6.13% | 7.30% | 8.95% |
Free Cash Flow Margin | - | 10.69% | -0.98% | -27.73% | -2.60% | -4.75% |
EBITDA | 255.81 | 248.28 | 181.55 | 113.62 | 165.42 | 169.68 |
EBITDA Margin | 14.78% | 15.91% | 14.87% | 10.92% | 11.30% | 13.91% |
D&A For EBITDA | 32.72 | 32.46 | 32.1 | 10.62 | 10.69 | 7.35 |
EBIT | 223.09 | 215.82 | 149.45 | 103 | 154.73 | 162.33 |
EBIT Margin | 12.89% | 13.83% | 12.24% | 9.90% | 10.57% | 13.30% |
Effective Tax Rate | 26.17% | 26.60% | 26.43% | 26.73% | 26.08% | 26.76% |
Revenue as Reported | 1,750 | 1,577 | 1,226 | 1,048 | 1,477 | 1,221 |
Advertising Expenses | - | 21.74 | 9.98 | 10.23 | 0.88 | 0.43 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.